Robert W. Simms

Rheumatology

72 E Concord St
Boston, MA 02118

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Journal: ACR open rheumatology

Published: February 06, 2025

Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm Trial.

Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm Trial.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 05, 2024

Geographic Clustering of Systemic Sclerosis in Areas of Environmental Pollution.

Geographic Clustering of Systemic Sclerosis in Areas of Environmental Pollution.

Journal: Arthritis care & research

Published: May 30, 2024

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 22, 2023

Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis.

Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis.

Journal: Arthritis research & therapy

Published: May 23, 2022

A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis.

A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis.

Journal: Journal of scleroderma and related disorders

Published: January 10, 2022

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.

Journal: The Lancet. Rheumatology

Published: December 30, 2021

Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.

Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: November 10, 2021

Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.

Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.

Journal: Rheumatology (Oxford, England)

Published: October 06, 2021

Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.

Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.

Journal: Arthritis care & research

Published: April 09, 2021

Reply.

Reply.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 17, 2020

Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in Scleroderma.

Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in Scleroderma.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 12, 2020

Showing 1-12 of 53

Last Updated: 09/26/2026